EP3122358
SAMSETNINGAR FGFR- OG CMET-HEMLA Í MEÐFERÐ VIÐ KRABBA
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
26.3.2015EP published:
16.12.2020EP application number:
15721129.3
EP translation filed:
1.3.2021Grant published:
15.3.2021EPO information:
European Patent Register
Max expiry date:
25.3.2035Expiry date:
25.3.2027Next due date:
31.3.2027
Title:
COMBINATIONS OF FGFR- AND CMET-INHIBITORS FOR THE TREATMENT OF CANCER
Timeline
Today
26.3.2015EP application
16.12.2020EP Publication
1.3.2021Translation submitted
15.3.2021Registration published
25.3.2027Expires
Owner
Name:
Astex Therapeutics Ltd.Address:
436 Cambridge Science Park Milton Road, Cambridge CB4 0QA, GB
Inventor
Name:
JOVCHEVA, EleonoraAddress:
2340 Beerse, BE
Name:
PERERA, Timothy Pietro SurenAddress:
2340 Beerse, BE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
14161835Date:
26.3.2014Country:
EP
Classification
Categories:
A61K 31/498, A61K 31/4985, A61K 31/5025, A61P 35/00, A61P 43/00
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 22.3.2021
Expires: 25.3.2022
Payer: Árnason Faktor ehf.
Number: 8
Paid: 21.3.2022
Expires: 25.3.2023
Payer: Árnason Faktor ehf.
Number: 9
Paid: 27.2.2023
Expires: 25.3.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 29.2.2024
Expires: 25.3.2025
Payer: Árnason Faktor ehf.
Number: 11
Paid: 13.2.2025
Expires: 25.3.2026
Payer: Árnason Faktor ehf.
Number: 12
Paid: 28.3.2026
Expires: 25.3.2027
Payer: Árnason Faktor ehf.